Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-14

Clinical Trial Update: The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane

View source ↗

Summary

A completed clinical trial evaluating intravitreal glucose for macular thinning after vitrectomy for retinal detachment or epiretinal membrane.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravitreal glucose (glucose)

Snippet

Sponsor: CHU de Reims | Conditions: Vitrectomy, Macular Thinning | Status: COMPLETED